Benzinga | Jul 30, 2020 06:36AM EDT

Alexion Pharmaceuticals Q2 Adj. EPS $3.11 Beats $2.59 Estimate, Sales $1.44B Beat $1.28B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $3.11 per share which beat the analyst consensus estimate of $2.59 by 20.08 percent. This is a 17.8 percent increase over earnings of $2.64 per share from the same period last year. The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.28 billion by 12.86 percent. This is a 20.08 percent increase over sales of $1.20 billion the same period last year.